NCT07417904 · RECRUITING
BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
This study tests BRAVE, a talk-therapy program based on cognitive behavioral therapy, for young adults with early psychosis. It aims to lower factors that can lead to violence. Researchers mainly want to know if it is workable and acceptable to participants. It is not a Phase 1-3 drug trial, and it does not test whether the program works.
You may qualify if
- Young adults aged 16-30 years
- Diagnosis of early psychosis
- Currently receiving outpatient care through an early psychosis clinic
- Psychiatrically stable and deemed appropriate for participation by a treating clinician
- Able and willing to provide informed consent
You're excluded if
- Unable to provide informed consent
- Not fluent in English
- History of antisocial behavior, as assessed at baseline
- Immediate risk requiring a higher level of care
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-07-29